Back
Recursion Pharmaceuticals Stock Predictions
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
RXRX
Recursion Pharmaceuticals
Last Price:
$5.75
Seasonality Move:
0.33%
7 Day Trial
ALL ACCESS PASS
$
7
Shocking Video Could Open Weekend Income Doors.
Go Here Now to Watch itRecursion Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 5.4% based on the past 3 years of stock performance.
-
Recursion Pharmaceuticals has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Recursion Pharmaceuticals Stock Undervalued?The current Recursion Pharmaceuticals [RXRX] share price is $5.76. The Score for RXRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 5.4% based on the past 3 years of stock performance.
Recursion Pharmaceuticals Stock Rating
Sell
30
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals overpriced?
-
Recursion Pharmaceuticals has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
12.36
52-Week Low:
3.79
Prediction Charts
Market Cap:
2.3B
Price in USD:
5.76
Volume:
83.4M
Beta:
1.00
Technical Analysis
SMA50:
6.88
SMA100:
6.90
SMA200:
6.99
52-Wk Change:
-35.43%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?Yes, Recursion Pharmaceuticals is a publicly traded company.
-
What is the Recursion Pharmaceuticals stock quote today?The Recursion Pharmaceuticals stock price is 5.76 USD today.
-
How to buy Recursion Pharmaceuticals stock online?You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-25 | 6.74 | 6.53 | 6.76 | 6.47 |
| Mar-26 | 6.52 | 6.17 | 6.54 | 6.08 |
| Mar-27 | 6.04 | 5.97 | 6.30 | 5.95 |
| Mar-28 | 5.95 | 5.81 | 6.01 | 5.77 |
| Mar-31 | 5.50 | 5.29 | 5.51 | 5.19 |
| Apr-1 | 5.32 | 5.10 | 5.34 | 5.00 |
| Apr-2 | 4.99 | 5.29 | 5.37 | 4.95 |
| Apr-3 | 4.91 | 4.81 | 5.03 | 4.78 |
| Apr-4 | 4.59 | 4.24 | 4.74 | 4.06 |
| Apr-7 | 3.96 | 4.20 | 4.60 | 3.80 |
| Apr-8 | 4.49 | 3.97 | 4.49 | 3.87 |
| Apr-9 | 3.89 | 4.65 | 4.97 | 3.79 |
| Apr-10 | 4.60 | 4.51 | 4.64 | 4.07 |
| Apr-11 | 5.00 | 5.76 | 6.00 | 4.86 |
Recursion Pharmaceuticals Earnings
Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Recursion Pharmaceuticals Forecast Revenue Growth
Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.17 per share, a decrease this year of $0.07 per share, and an increase next year of $0.24 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.